A role of ADAR2 and RNA editing of glutamate receptors in mood disorders and schizophrenia

Molecular Brain

Volumn 7, Issue 1, 2014, Pages

  Kubota Sakashita, Mie ^a   Iwamoto, Kazuya ^a,b   Bundo, Miki ^a,b   Kato, Tadafumi ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Adenosine deaminase acting on RNA type 2; AMPA kainate receptors; RNA editing; Serotonin 2C receptor

Indexed keywords

ADENOSINE DEAMINASE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOOD DISORDERS; MOTOR ACTIVITY; POSTMORTEM CHANGES; QUINOXALINES; RECEPTORS, AMPA; RECEPTORS, GLUTAMATE; RNA EDITING; RNA-BINDING PROTEINS; SCHIZOPHRENIA;

EID: 84892592481     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/1756-6606-7-5     Document Type: Article

References (43)

1. Neurobiology of Mental Illness New York: Oxford University Press, Charney D, Nestler S, Eric J, 2011
2. Glutamatergic theories of schizophrenia. Javitt DC, Isr J Psychiatry Relat Sci 2010 47 4 16 20686195
3. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK, Arch Gen Psychiatry 2006 63 856 864 10.1001/archpsyc.63.8.856 16894061 (Pubitemid 44188478)
4. Serotonin receptor 2C and mental disorders: genetic, expression and RNA editing studies. Iwamoto K, Bundo M, Kato T, RNA Biol 2009 6 248 253 10.4161/rna.6.3.8370 19411841
5. Glutamate receptor RNA editing in health and disease. Barbon A, Barlati S, Biochemistry (Mosc) 2011 76 882 889 10.1134/S0006297911080037 22022961
6. Deregulation of the A-to-I RNA editing mechanism in psychiatric disorders. Silberberg G, Lundin D, Navon R, Ohman M, Hum Mol Genet 2012 21 311 321 10.1093/hmg/ddr461 21984433
7. Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. Lomeli H, Mosbacher J, Melcher T, Hoger T, Geiger JR, Kuner T, Monyer H, Higuchi M, Bach A, Seeburg PH, Science 1994 266 1709 1713 10.1126/science.7992055 7992055
8. RNA editing and alternative splicing of human serotonin 2C receptor in schizophrenia. Dracheva S, Elhakem SL, Marcus SM, Siever LJ, McGurk SR, Haroutunian V, J Neurochem 2003 87 1402 1412 10.1046/j.1471-4159.2003.02115.x 14713296 (Pubitemid 38020574)
9. RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy. Niswender CM, Herrick-Davis K, Dilley GE, Meltzer HY, Overholser JC, Stockmeier CA, Emeson RB, Sanders-Bush E, Neuropsychopharmacology 2001 24 478 491 10.1016/S0893-133X(00) 00223-2 11282248 (Pubitemid 32244309)
10. Increased serotonin 2C receptor mRNA editing: a possible risk factor for suicide. Dracheva S, Patel N, Woo DA, Marcus SM, Siever LJ, Haroutunian V, Mol Psychiatry 2008 13 1001 1010 10.1038/sj.mp.4002081 17848916
11. Quantitative analysis of focused a-to-I RNA editing sites by ultra-high-throughput sequencing in psychiatric disorders. Zhu H, Urban DJ, Blashka J, McPheeters MT, Kroeze WK, Mieczkowski P, Overholser JC, Jurjus GJ, Dieter L, Mahajan GJ, Rajkowska G, Wang Z, Sullivan PF, Stockmeier CA, Roth BL, PLoS One 2012 7 43227 10.1371/journal.pone.0043227 22912834
12. RNA editing of serotonin 2C receptor in human postmortem brains of major mental disorders. Iwamoto K, Kato T, Neurosci Lett 2003 346 169 172 10.1016/S0304-3940(03)00608-6 12853111 (Pubitemid 36829288)
13. RNA editing of the 5-HT(2C) receptor is reduced in schizophrenia. Sodhi MS, Burnet PW, Makoff AJ, Kerwin RW, Harrison PJ, Mol Psychiatry 2001 6 373 379 10.1038/sj.mp.4000920 11443520 (Pubitemid 32566085)
14. Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Gurevich I, Tamir H, Arango V, Dwork AJ, Mann JJ, Schmauss C, Neuron 2002 34 349 356 10.1016/S0896-6273(02)00660-8 11988167 (Pubitemid 34465494)
15. Serotonin 2c receptor RNA editing in major depression and suicide. Lyddon R, Dwork AJ, Keddache M, Siever LJ, Dracheva S, World J Biol Psychiatry 2012 14 590 601 22404657
16. Editing for an AMPA receptor subunit RNA in prefrontal cortex and striatum in Alzheimer's disease, Huntington's disease and schizophrenia. Akbarian S, Smith MA, Jones EG, Brain Res 1995 699 297 304 10.1016/0006-8993(95) 00922-D 8616634
17. Ionotropic glutamate receptor mRNA editing in the prefrontal cortex: no alterations in schizophrenia or bipolar disorder. Lyddon R, Navarrett S, Dracheva S, J Psychiatry Neurosci 2012 37 267 272 10.1503/jpn.110107 22469055
18. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Sanacora G, Treccani G, Popoli M, Neuropharmacology 2012 62 63 77 10.1016/j.neuropharm.2011.07.036 21827775
19. Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Tomita H, Vawter MP, Walsh DM, Evans SJ, Choudary PV, Li J, Overman KM, Atz ME, Myers RM, Jones EG, Watson SJ, Akil H, Bunney WE Jr, Biol Psychiatry 2004 55 346 352 10.1016/j.biopsych.2003.10.013 14960286 (Pubitemid 38199983)
20. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Iwamoto K, Bundo M, Kato T, Hum Mol Genet 2005 14 241 253 15563509
21. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Higuchi M, Maas S, Single FN, Hartner J, Rozov A, Burnashev N, Feldmeyer D, Sprengel R, Seeburg PH, Nature 2000 406 78 81 10.1038/35017558 10894545 (Pubitemid 30460214)
22. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Wolf ME, Prog Neurobiol 1998 54 679 720 10.1016/S0301-0082(97)00090-7 9560846 (Pubitemid 28137703)
23. Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: studies on the involvement of dopamine. Reid MS, Hsu K Jr, Berger SP, Synapse 1997 27 95 105 10.1002/(SICI)1098-2396(199710)27:2<95:: AID-SYN1>3.0.CO;2-6 9266771 (Pubitemid 27349713)
24. Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine. Li Y, Vartanian AJ, White FJ, Xue CJ, Wolf ME, Psychopharmacology (Berl) 1997 134 266 276 10.1007/s002130050449 9438676 (Pubitemid 27520980)
25. Effects of AMPA receptor antagonists on dopamine-mediated behaviors in mice. Vanover KE, Psychopharmacology (Berl) 1998 136 123 131 10.1007/s002130050547 9551768 (Pubitemid 28137951)
26. Increased cortical expression of an RNA editing enzyme occurs in major depressive suicide victims. Simmons M, Meador-Woodruff JH, Sodhi MS, Neuroreport 2010 21 993 997 20802353
27. Novel splice variants of human ADAR2 mRNA: skipping of the exon encoding the dsRNA-binding domains, and multiple C-terminal splice sites. Kawahara Y, Ito K, Ito M, Tsuji S, Kwak S, Gene 2005 363 193 201 16297572 (Pubitemid 41691908)
28. RNA-interacting proteins act as site-specific repressors of ADAR2-mediated RNA editing and fluctuate upon neuronal stimulation. Tariq A, Garncarz W, Handl C, Balik A, Pusch O, Jantsch MF, Nucleic Acids Res 2013 41 2581 2593 10.1093/nar/gks1353 23275536
29. Therapeutic implications of down-regulation of cyclophilin D in bipolar disorder. Kubota M, Kasahara T, Iwamoto K, Komori A, Ishiwata M, Miyauchi T, Kato T, Int J Neuropsychopharmacol 2010 13 1355 1368 10.1017/S1461145710000362 20392297
30. Widespread RNA and DNA sequence differences in the human transcriptome. Li M, Wang IX, Li Y, Bruzel A, Richards AL, Toung JM, Cheung VG, Science 2011 333 53 58 10.1126/science.1207018 21596952
31. Extensive genomic and transcriptional diversity identified through massively parallel DNA and RNA sequencing of eighteen Korean individuals. Ju YS, Kim JI, Kim S, Hong D, Park H, Shin JY, Lee S, Lee WC, Yu SB, Park SS, Seo SH, Yun JY, Kim HJ, Lee DS, Yavartanoo M, Kang HP, Gokcumen O, Govindaraju DR, Jung JH, Chong H, Yang KS, Kim H, Lee C, Seo JS, Nat Genet 2011 43 745 752 10.1038/ng.872 21725310
32. Accurate identification of A-to-I RNA editing in human by transcriptome sequencing. Bahn JH, Lee JH, Li G, Greer C, Peng G, Xiao X, Genome Res 2012 22 142 150 10.1101/gr.124107.111 21960545
33. Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome. Peng Z, Cheng Y, Tan BC, Kang L, Tian Z, Zhu Y, Zhang W, Liang Y, Hu X, Tan X, Guo J, Dong Z, Bao L, Wang J, Nat Biotechnol 2012 30 253 260 10.1038/nbt.2122 22327324
34. Accurate identification of human Alu and non-Alu RNA editing sites. Ramaswami G, Lin W, Piskol R, Tan MH, Davis C, Li JB, Nat Methods 2012 9 579 581 10.1038/nmeth.1982 22484847
35. Very few RNA and DNA sequence differences in the human transcriptome. Schrider DR, Gout JF, Hahn MW, PLoS One 2011 6 25842 10.1371/journal.pone. 0025842 22022455
36. A novel computational strategy to identify A-to-I RNA editing sites by RNA-Seq data: de novo detection in human spinal cord tissue. Picardi E, Gallo A, Galeano F, Tomaselli S, Pesole G, PLoS One 2012 7 44184 10.1371/journal.pone. 0044184 22957051
37. Requirement of the RNA-editing enzyme ADAR2 for normal physiology in mice. Horsch M, Seeburg PH, Adler T, Aguilar-Pimentel JA, Becker L, Calzada-Wack J, Garrett L, Gotz A, Hans W, Higuchi M, Holter SM, Naton B, Prehn C, Puk O, Racz I, Rathkolb B, Rozman J, Schrewe A, Adamski J, Busch DH, Esposito I, Graw J, Ivandic B, Klingenspor M, Klopstock T, Mempel M, Ollert M, Schulz H, Wolf E, Wurst W, et al. J Biol Chem 2011 286 18614 18622 10.1074/jbc.M110.200881 21467037
38. Affect-related behaviors in mice misexpressing the RNA editing enzyme ADAR2. Singh M, Zimmerman MB, Beltz TG, Johnson AK, Physiol Behav 2009 97 446 454 10.1016/j.physbeh.2009.03.029 19361536
39. Altered ADAR 2 equilibrium and 5HT(2C) R editing in the prefrontal cortex of ADAR 2 transgenic mice. Singh M, Singh MM, Na E, Agassandian K, Zimmerman MB, Johnson AK, Genes Brain Behav 2011 10 637 647 10.1111/j.1601-183X.2011. 00701.x 21615684
40. The stanley foundation brain collection and neuropathology consortium. Torrey EF, Webster M, Knable M, Johnston N, Yolken RH, Schizophr Res 2000 44 151 155 10.1016/S0920-9964(99)00192-9 10913747 (Pubitemid 30411930)
41. Association AP, Diagnostic and Statistical Manual of Mental Disorders Arlington, VA: American Psychiatric Publishing 4 1994
42. Effects of cocaine and reserpine administration on RNA editing of rat 5-HT2C receptor estimated by primer extension combined with denaturing high-performance liquid chromatography. Iwamoto K, Kato T, Pharmacogenomics J 2002 2 335 340 10.1038/sj.tpj.6500130 12439740 (Pubitemid 35439476)
43. Estimating RNA editing efficiency of five editing sites in the serotonin 2C receptor by pyrosequencing. Iwamoto K, Bundo M, Kato T, RNA 2005 11 1596 1603 10.1261/rna.2114505 16199765 (Pubitemid 41396930)